Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 895-901

  De Waele, Jean Pascal ^a   Audet, Robert M ^a   Leong, Dorothy K ^a   Butterworth, Roger F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 METHIONINOL SULFOXIDE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; HYPOPHYSIS; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PATHOGENESIS; PORTOCAVAL SHUNT; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

EID: 0029810137     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855194     Document Type: Article

References (47)

1. Laidlaw J, Read AE, Sherlock S. Morphine tolerance in hepatic cirrhosis. Gastroenterology 1961;40:389-396.
2. Salomon F, Beaubernard C, Thangapregassam MJ, Grange D, Bismuth H. Encéphalopathie hépatique expérimentale. II. Étude de la réaction à la douleur chez le rat avec anastomose porto-cave. Biol Gastroenterol 1976; 9:105-108.
3. Van Ree JM, de Wied D, Bradbury AF, Hulme EC, Smyth DG, Snell CR. Induction of tolerance to the analgesic action of lipotropin C-fragment. Nature 1976;64:792-794.
4. Martin JR, Porchet H, Buhler R, Bircher J. Increased ethanol consumption and blood ethanol levels in rats with portacaval shunts. Am J Physiol 1985;248:G287-G292.
5. Sirnes TB. Voluntary consumption of alcohol in rats with cirrhosis of the liver. Q J Stud Alcohol 1953;14:3-18
6. Blum K, Futterman S, Wallace JE, Schwertner HA. Naloxone-induced inhibition of ethanol dependence in mice. Nature 1977;265:49-51.
7. Altshuler HL, Phillips PP, Feinhandler DA. Alteration of ethanol self-administration by naltrexone. Life Sci 1980;26:679-688.
8. Froehlich JC, Harts J, Lumeng L, Li TK. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 1990;35:385-390.
9. Kornet M, Goosen C, Van Ree JM. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 1991; 104:367-376.
10. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiat 1992;49:876-880.
11. O'Malley SS, Jaffe AJ, Chang G, Scottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiat 1992;49:881-887.
12. Van Ree JM, Smyth DG, Colpaert FC. Dependence creating properties of lipotropin C-fragment 'β-endorphin': evidence for its internal control of behavior. Life Sci 1979;24:495-502.
13. Khachaturian H, Lewis ME, Schafer MKH, Watson SJ. Anatomy of the CNS opioid systems. Trends Neurol Sci 1985;10:111-119.
14. Tseng LF, Tang R. Different mechanisms mediate β-endorphin and morphine induced inhibition of the tail-flick response in rats. J Pharmacol Exp Ther 1990;252:546-551.
15. Olson GA, Olson RD, Kastin AJ. Endogenous opiates: 1990. Peptides 1991; 12:1407-1432.
16. Routtenberg A. Self-stimulation pathways: origins and terminations - a three stage technique. In: Wauquier A, Rolls BJ, eds. Brain-stimulation reward. Amsterdam: Elsevier/North Holland Biomedical Press, 1976:31-39.
17. Charness ME. Ethanol and opioid receptor signalling. Experientia 1989; 45:418-428.
18. Thornton JR, Losowsky MS. Plasma methionone enkephalin concentration and prognosis in primary biliary cirrhosis. Br Med J 1988;297:1241-1242.
19. Thornton JR, Losowsky MS. A role for the kidneys and liver in plasma beta-endorphin elimination? [Abstract] Clin Sci 1988; 74(suppl 18):51.
20. Zeneroli ML, Baraldi M, Ventura E, Zanoli P, Vezzeli C, Russo AM. Beta-endorphin and opiate receptor changes in acute and chronic models of hepatic encephalopathy. In: Butterworth RF, Pomier Layrargues G, eds. Hepatic encephalopathy: pathophysiology and treatment. Clifton: Humana Press Inc, 1988:455-466.
21. Panerai AE, Salerno F, Baldissera F, Martini A, Di Giulio AM, Mantegazza P. Bain β-endorphin concentrations in experimental chronic liver disease. Brain Res 1982;247:188-190.
22. Butterworth RF, Girard G, Giguère JF. Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis. J Neurochem 1988;51:486-490.
23. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press, 1986.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
25. Hunter WM, Greenwood FC. Preparation of iodine-131-labelled human growth hormone of high specific activity. Nature 1962;194:265-275.
26. 6. Mol Pharmacol 1988;34:436-442.
27. Moyse E, Pasquini F, Quirion R, Beaudet A. [125I]-FK-33-824: a selective probe for radioautographic labeling of mu opioid receptors in the brain. Peptides 1986;7:351-355.
28. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. Br Med J 1988;297:1501-1504.
29. Thornton JR, Dean H, Losowski MS. Is ascites caused by impaired hepatic inactivation of blood-borne endogenous opioid peptides? Gut 1988;29:1167-1172.
30. 14C]amino acid profiles in discrete hypothalamic regions during push-pull perfusion in the unrestrained rat. Neuroscience 1979;4:495-506.
31. Tiligada E, Wilson JF. Glutaminergic action on alpha-melanocyte - stimulating hormone release from the rat hypothalamus. J Neuroendocrinol 1989;1:393-395.
32. Giguère JF, Butterworth RF. Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res 1984;9:1039-1321.
33. Kupfermann I. Hypothalamus and limbic system: peptidergic neurons, homeostasis, and emotional behavior. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural sciences, Vol 3. New York: Elsevier, 1991: 735-749.
34. Brady LS, Herkenham M, Long JB, Rothman RB. Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res 1989;477:382-386.
35. L'Hérault S, Barden N. Regulation of proopiomelanocortin messenger RNA concentrations by opioid peptides in primary cell cultures of rat hypothalamus. Mol Brain Res 1991;10:115-121.
36. Weilland NG, Wise PM. Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology 1990;126:804-808.
37. Guyton AC. Somatic sensations: II. Pain, visceral pain, headache, and thermal sensations. In: Dreibelbis D, ed. Textbook of medical physiology, Vol 7. Philadelphia: Saunders, 1986:592-605.
38. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992;15:220-224.
39. de Waele JP, Kiianmaa K, Gianoulakis C. Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther 1995;275:518-527.
40. McBride WJ, Chernet E, Guan XM, Lumeng L, Li TK. Densities of opioid receptors in the CNS of alcohol-preferring (P) and non-preferring (NP) lines of rats [Abstract]. Soc Neurosci Abstracts 1990, 434.
41. de Waele JP, Gianoulakis C. Autoradiographic localization of the μ and δ receptors in the brain of mice selected for their differences in voluntary ethanol consumption [Abstract]. Soc Neurosci Abstracts 1992;18:269.
42. Le AD, Chow S. Reduction of ethanol intake in C57BL mice by opiate receptor antagonist. Alcohol Alcohol 1992;27(suppl 1):41-49.
43. Acquas E, Meloni M, Di Chiara G. Blockade of δ-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol 1993;230:139-241.
44. Beaubernard C, Salomon F, Grange F, Thangapregassam MJ, Bismuth H. Experimental hepatic encephalopathy. Changes of the level of wakefulness in the rat with portacaval shunt. Biomedicine 1977;27:169-171.
45. Conn HO. The hepatic encephalopathies. In: Conn HO, Bircher J, eds. Hepatic encephalopathy: management with lactulose and related carbohydrates. East Lansing: Medi-Ed Press, 1989:3-13.
46. Yurdaydin C, Li Y, Ha JH, Jones A, Rothman R, Basile AS. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists. J Pharmacol Exp Ther 1995; 273:185-192.
47. Özsoylu S, Kocak N. Naloxone in hepatic encephalopathy. Am J Dis Child 1985;139:749-750.